Keros Therapeutics, Inc. (KROS)
NASDAQ: KROS · Real-Time Price · USD
13.74
+0.09 (0.66%)
At close: May 12, 2025, 4:00 PM
14.00
+0.26 (1.89%)
After-hours: May 12, 2025, 6:51 PM EDT

Keros Therapeutics Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2018 - 2019
Period Ending
Mar '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2018 - 2019
Revenue
214.713.550.15-20.1-
Upgrade
Revenue Growth (YoY)
91657.69%2250.99%----
Upgrade
Cost of Revenue
10.45---55.1433.86
Upgrade
Gross Profit
204.263.550.15--35.04-33.86
Upgrade
Selling, General & Admin
40.9440.7534.8327.5321.3312.8
Upgrade
Research & Development
173.63173.63135.2687.27--
Upgrade
Operating Expenses
214.57214.38170.09114.7921.3312.8
Upgrade
Operating Income
-10.31-210.83-169.94-114.79-56.37-46.66
Upgrade
Interest Expense
----0-0-0.01
Upgrade
Interest & Investment Income
24.4823.514.763.640.03-
Upgrade
Currency Exchange Gain (Loss)
-0.86-0.95-0.21-0.61--
Upgrade
Other Non Operating Income (Expenses)
1.241.242.47.08-0.381.13
Upgrade
Pretax Income
14.56-187.05-152.99-104.68-56.73-45.53
Upgrade
Income Tax Expense
10.340.3--2.01-0.17
Upgrade
Net Income
4.21-187.35-152.99-104.68-58.74-45.36
Upgrade
Net Income to Common
4.21-187.35-152.99-104.68-58.74-45.36
Upgrade
Shares Outstanding (Basic)
393729252316
Upgrade
Shares Outstanding (Diluted)
393729252316
Upgrade
Shares Change (YoY)
23.97%27.13%16.66%8.17%50.48%566.41%
Upgrade
EPS (Basic)
0.11-5.00-5.20-4.15-2.52-2.93
Upgrade
EPS (Diluted)
0.11-5.00-5.20-4.15-2.52-2.93
Upgrade
Free Cash Flow
43.31-162.8-126.97-71.3-63.17-37.19
Upgrade
Free Cash Flow Per Share
1.12-4.35-4.31-2.83-2.71-2.40
Upgrade
Gross Margin
95.13%100.00%100.00%--174.34%-
Upgrade
Operating Margin
-4.80%-5938.96%-112543.71%--280.46%-
Upgrade
Profit Margin
1.96%-5277.55%-101319.21%--292.26%-
Upgrade
Free Cash Flow Margin
20.17%-4585.91%-84087.42%--314.29%-
Upgrade
EBITDA
-9.01-209.6-169.13-114.12-56-46.38
Upgrade
EBITDA Margin
-4.20%----278.58%-
Upgrade
D&A For EBITDA
1.31.230.820.670.380.28
Upgrade
EBIT
-10.31-210.83-169.94-114.79-56.37-46.66
Upgrade
EBIT Margin
-4.80%----280.46%-
Upgrade
Revenue as Reported
214.713.550.15-20.1-
Upgrade
Updated Feb 26, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q